L.P. ACORN BIOVENTURES

Insider Reports History

Location
New York, NY
Signature
ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by L.P. ACORN BIOVENTURES:

Company Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 1,439,674 $3,845,369 $2.67 04 Oct 2024 Direct
OnKure Therapeutics, Inc. 10%+ Owner Common Stock 1,709,944 $3,163,396 $1.85 15 May 2025 Direct
OnKure Therapeutics, Inc. 10%+ Owner Common Stock 1,129,730 $2,090,000 $1.85 15 May 2025 By Acorn Bioventures 2, L.P.

Insider Reports Filed by L.P. ACORN BIOVENTURES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 15 May 2025 2 +$2,590,000 4 10%+ Owner 19 May 2025, 16:43
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 10%+ Owner 09 Oct 2024, 16:15